Vaccine safety versus vaccine efficacy in mass immunisation programmes
- 23 November 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 338 (8778), 1309-1312
- https://doi.org/10.1016/0140-6736(91)92601-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Modelling forces of infection for measles, mumps and rubellaStatistics in Medicine, 1990
- Serological study of the epidemiology of mumps virus infection in north-west EnglandEpidemiology and Infection, 1990
- Surveillance of antibody to measles, mumps, and rubella by age.BMJ, 1988
- Interference between strains in live virus vaccines I: combined vaccination with measles, mumps and rubella vaccineJournal of Biological Standardization, 1988
- The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunizationEpidemiology and Infection, 1987
- A controlled trial for evaluating two live attenuated mumps‐measles vaccines (Urabe Am 9‐Schwarz and Jeryl Lynn‐Moraten) in young childrenJournal of Medical Virology, 1986
- The estimation of age-related rates of infection from case notifications and serological dataEpidemiology and Infection, 1985
- Age-related changes in the rate of disease transmission: implications for the design of vaccination programmesEpidemiology and Infection, 1985
- COMPARISON OF THE URABE AM 9‐SCHWARZ AND JERYL LYNN‐MORATEN COMBINATIONS OF MUMPS‐MEASLES VACCINES IN YOUNG CHILDRENActa Paediatrica, 1983
- The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildrenJournal of Biological Standardization, 1983